Effects of supplementation of the synbiotic Ecologic® 825/FOS P6 on intestinal barrier function in healthy humans: A randomized controlled trial

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Wilms, E ^a   Gerritsen, J ^b,c   Smidt, H ^b   Besseling Van Der Van Vaart, I ^c   Rijkers, G T ^d,e   Fuentes, A R Garcia ^a   Masclee, A A M ^a   Troost, F J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c WINCLOVE PROBIOTICS   (Netherlands)

^d University College Roosevelt   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; FRUCTOSE OLIGOSACCHARIDE; INDOMETACIN; LACTULOSE; PEPTIDES AND PROTEINS; RHAMNOSE; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; ZONULIN; CARBOHYDRATE; CHOLERA TOXIN; PREBIOTIC AGENT; PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; INTESTINE MUCOSA PERMEABILITY; LIMIT OF DETECTION; MALE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STOOL FREQUENCY; URINARY EXCRETION; BLOOD; DEFECATION; INTESTINE; INTESTINE ABSORPTION; METABOLISM; URINE; YOUNG ADULT;

ADULT; CARBOHYDRATES; CHOLERA TOXIN; CYTOKINES; DEFECATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINAL ABSORPTION; INTESTINES; MALE; PREBIOTICS; PROBIOTICS; SYNBIOTICS; YOUNG ADULT;

EID: 85005978182     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167775     Document Type: Article

References (44)

1. Blair SA, Kane SV, Clayburgh DR, Turner JR. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest. 2006 Jan 9;86(2):191-201. doi: 10. 1038/labinvest.3700373 PMID: 16402035
2. Mankertz J, Schulzke J. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications: Curr Opin Gastroenterol. 2007 Jul; 23(4):379-83. doi: 10.1097/MOG. 0b013e32816aa392 PMID: 17545772
3. Kuitunen M, Savilahti E. Gut permeability to human alpha-lactalbumin, beta-lactoglobulin, mannitol, and lactulose in celiac disease. J Pediatr Gastroenterol Nutr. 1996 Feb; 22(2):197-204. PMID: 8642494
4. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S, et al. Gastrointestinal permeability in celiac disease. Gastroenterology. 1997 Apr; 112(4):1129-36. PMID: 9097995
5. Hedin CR, Stagg AJ, Whelan K, Lindsay JO. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention. Gut. 2012 Feb. 1;61(2):311-8. doi: 10.1136/gut. 2011.238568 PMID: 21561876
6. Lee SH. Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases. Intest Res. 2015;13(1):11. doi: 10.5217/ir.2015.13.1.11 PMID: 25691839
7. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer R-JM, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol-Gastrointest Liver Physiol. 2010 Jun. 1;298(6):G851-9. doi: 10.1152/ajpgi.00327.2009 PMID: 20224007
8. Gotteland M, Cruchet S, Verbeke S. Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans. Aliment Pharmacol Ther. 2001 Jan 17;15(1):11-7. PMID: 11136273
9. Russo F, Linsalata M, Clemente C, Chiloiro M, Orlando A, Marconi E, et al. Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutr Res. 2012 Dec; 32(12):940-6. doi: 10.1016/j.nutres.2012.09.010 PMID: 23244539
10. Del Piano M, Balzarini M, Carmagnola S, Pagliarulo M, Tari R, Nicola S, et al. Assessment of the Capability of a Gelling Complex Made of Tara Gum and the Exopolysaccharides Produced by the Microorganism Streptococcus thermophilus ST10 to Prospectively Restore the Gut Physiological Barrier: A Pilot Study. J Clin Gastroenterol. 2014;48:S56-61. doi: 10.1097/MCG.0000000000000254 PMID: 25291130
11. Bruggencate SJMT, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, Meer R van der. Dietary Fructooligosaccharides Affect Intestinal Barrier Function in Healthy Men. J Nutr. 2006 Jan 1;136(1):70-4. PMID: 16365061
12. Persborn M, Gerritsen J, Wallon C, Carlsson A, Akkermans LMA, Söderholm JD. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther. 2013 Oct. 1;38(7):772-83. doi: 10.1111/apt. 12451 PMID: 23957603
13. Lutgendorff F, Carlsson AH, Timmerman HM, Akkermans LMA, Söderholm JD. Role of mast cells and PPAR-y. In: Defending the barrier. Amsterdam Thesis, Utrecht University; 2009.
14. Lutgendorff F, Carlsson AH, Akkermans LMA, McKay DM, Söderholm JD. Probiotics modulate mast cell degranulation and reduce stress-induced barrier dysfunction in vitro. In: Defending the barrier. Amsterdam Thesis, Utrecht University; 2009.
15. van Wijck K, Verlinden TJM, van Eijk HMH, Dekker J, Buurman WA, Dejong CHC, et al. Novel multisugar assay for site-specific gastrointestinal permeability analysis: A randomized controlled crossover trial. Clin Nutr. 2013 Apr; 32(2):245-51. doi: 10.1016/j.clnu.2012.06.014 PMID: 22892368
16. van Wijck K, van Eijk HMH, Buurman WA, Dejong CHC, Lenaerts K. Novel analytical approach to a multi-sugar whole gut permeability assay. J Chromatogr B. 2011 Sep. 15;879(26):2794-801.
17. Salden BN, Monserrat V, Troost FJ, Bruins MJ, Edens L, Bartholomé R, et al. Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers. Aliment Pharmacol Ther. 2015 Aug. 1;42(3):273-85. doi: 10.1111/apt.13266 PMID: 26040627
18. Somasundaram S, Rafi S, Hayllar J, Sigthorsson G, Jacob M, Price AB, et al. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut. 1997 Sep. 1;41(3):344-53. PMID: 9378390
19. Troost FJ, Saris WHM, Brummer R-JM. Recombinant human lactoferrin ingestion attenuates indomethacininduced enteropathy in vivo in healthy volunteers. Eur J Clin Nutr. 2003;57(12):1579-85. doi: 10. 1038/sj.ejcn. 1601727 PMID: 14647223
20. Korhonen R, Kosonen O, Korpela R, Moilanen E. The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett Appl Microbiol. 2004 Jul. 1;39(1):19-24. doi: 10.1111/j.1472-765X.2004.01531.x PMID: 15189283
21. Hsieh C-Y, Osaka T, Moriyama E, Date Y, Kikuchi J, Tsuneda S. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum. Physiol Rep. 2015 Mar. 16;3(3):e12327. doi: 10.14814/phy2.12327 PMID: 25780093
22. Parassol N, Freitas M, Thoreux K, Dalmasso G, Bourdet-Sicard R, Rampal P. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol. 2005 Mar; 156(2):256-62. doi: 10.1016/j.resmic.2004.09.013 PMID: 15748992
23. Eun CS, Kim YS, Han DS, Choi JH, Lee AR, Park YK. Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. APMIS. 2011 Jan 1;119(1):49-56. doi: 10.1111/j.1600-0463.2010. 02691.x PMID: 21143526
24. Qin H, Zhang Z, Hang X, Jiang Y. L. plantarum prevents Enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 2009;9:63. doi: 10.1186/1471-2180-9-63 PMID: 19331693
25. Sapone A, Magistris L de, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives. Diabetes. 2006 May 1;55(5):1443-9. PMID: 16644703
26. Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, FernaAndez-Real JM. Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance. PLoS ONE. 2012 May 18;7(5):e37160. doi: 10.1371/journal.pone.0037160 PMID: 22629362
27. Hemert S van, Verwer J, SchuEtz B. Clinical Studies Evaluating Effects of Probiotics on Parameters of Intestinal Barrier Function. Adv Microbiol. 2013;3(2):212-21.
28. Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, et al. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr. 2012 Sep. 20;9(1):45. doi: 10.1186/1550-2783-9-45 PMID: 22992437
29. Hepburn NJ, Garaiova I, Williams EA, Michael DR, Plummer S. Probiotic supplement consumption alters cytokine production from peripheral blood mononuclear cells: a preliminary study using healthy individuals. Benef Microbes. 2013 Dec. 1;4(4):313-7. doi: 10.3920/BM2013.0012 PMID: 24311314
30. Plaza-Diaz J, Gomez-Llorente C, Campana-Martin L, Matencio E, Ortuno I, MartoAnez-Silla R, et al. Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study. PLoS ONE. 2013 Oct. 28;8(10):e78111. doi: 10.1371/journal.pone.0078111 PMID: 24205115
31. Sierra S, Lara-Villoslada F, Sempere L, Olivares M, Boza J, Xaus J. Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe. 2010 Jun; 16(3):195-200. doi: 10.1016/j.anaerobe.2010.02.001 PMID: 20159049
32. Mangalat N, Liu Y, Fatheree NY, Ferris MJ, Van Arsdall MR, Chen Z, et al. Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial. PLoS ONE. 2012 Sep. 6;7(9):e43910. doi: 10.1371/journal.pone.0043910 PMID: 22970150
33. Ulsemer P, Toutounian K, Kressel G, Schmidt J, Karsten U, Hahn A, et al. Safety and tolerance of Bacteroides xylanisolvens DSM 23964 in healthy adults. Benef Microbes. 2012 Mar. 14;3(2):99-111. doi: 10.3920/BM2011.0051 PMID: 22417778
34. Lomax AR, Cheung LVY, Tuohy KM, Noakes PS, Miles EA, Calder PC. β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. Br J Nutr. 2012 Nov; 108(10):1818-1828. doi: 10.1017/S0007114511007276 PMID: 22244014
35. Sullivan KE, Cutilli J, Piliero LM, Ghavimi-Alagha D, Starr SE, Campbell DE, et al. Measurement of Cytokine Secretion, Intracellular Protein Expression, and mRNA in Resting and Stimulated Peripheral Blood Mononuclear Cells. Clin Diagn Lab Immunol. 2000 Nov; 7(6):920-4. PMID: 11063499
36. Verdenelli MC, Silvi S, Cecchini C, Orpianesi C, Cresci A. Influence of a combination of two potential probiotic strains, Lactobacillus rhamnosus IMC 501R and Lactobacillus paracasei IMC 502R on bowel habits of healthy adults. Lett Appl Microbiol. 2011 Jun. 1;52(6):596-602. doi: 10.1111/j.1472-765X. 2011.03042.x PMID: 21395626
37. Ouwehand AC, Tiihonen K, Saarinen M, Putaala H, Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: intestinal and immune parameters. Br J Nutr. 2009 Feb; 101(3):367-375. doi: 10.1017/S0007114508003097 PMID: 18634707
38. Olivares M, Díaz-Ropero MP, Gómez N, Lara-Villoslada F, Sierra S, Maldonado JA, et al. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol. 2006 Mar. 15;107(2):104-11. doi: 10.1016/j.ijfoodmicro.2005.08.019 PMID: 16271414
39. Scholtens PAMJ, Alles MS, Willemsen LEM, van den Braak C, Bindels JG, Boehm G, et al. Dietary fructo-oligosaccharides in healthy adults do not negatively affect faecal cytotoxicity: a randomised, doubleblind, placebo-controlled crossover trial. Br J Nutr. 2006 Jun; 95(6):1143-1149. PMID: 16768837
40. Damen B, Cloetens L, Broekaert WF, François I, Lescroart O, Trogh I, et al. Consumption of Breads Containing In Situ-Produced Arabinoxylan Oligosaccharides Alters Gastrointestinal Effects in Healthy Volunteers. J Nutr. 2012 Mar. 1;142(3):470-7. doi: 10.3945/jn. 111.146464 PMID: 22298569
41. Matsumoto K, Takada T, Shimizu K, Moriyama K, Kawakami K, Hirano K, et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J Biosci Bioeng. 2010 Nov; 110(5):547-52. doi: 10.1016/j.jbiosc.2010.05.016 PMID: 20580604
42. Wind RD, Tolboom H, Klare I, Huys G, Knol J. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br J Nutr. 2010 Dec; 104(12):1806-1816. doi: 10.1017/S0007114510002746 PMID: 20691131
43. Sapone A, Lammers KM, Casolaro V, Cammarota M, Giuliano MT, De Rosa M, et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med. 2011;9:23. doi: 10.1186/1741-7015-9-23 PMID: 21392369
44. Van Nieuwenhoven MA, Geerling BJ, Deutz NEP, Brouns F, Brummer R-JM. The sensitivity of the lactulose/rhamnose gut permeability test. Eur J Clin Invest. 1999 Feb. 1;29(2):160-5. PMID: 10093003